Watch out for these signs of skin cancer, experts say
It can be alarming to see a new spot appear on your skin, especially if it's rapidly growing. Here's what experts need you to ...
Cure Today1d
Ficerafusp Alfa Trial Begins for Recurrent/Metastatic Head and Neck Cancer
Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with Keytruda for first-line treatment.
Targeted Oncology1d
FDA Grants Breakthrough Therapy Status to Petosemtamab/Pembrolizumab in HNSCC
The FDA granted breakthrough therapy status to first-line petosemtamab plus pembrolizumab for PD-L1–positive recurrent or ...